140 related articles for article (PubMed ID: 10623774)
1. The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling.
Erickson KD; Martin JM
J Virol; 2000 Jan; 74(2):1057-60. PubMed ID: 10623774
[TBL] [Abstract][Full Text] [Related]
2. Unexpected absence of the Epstein-Barr virus (EBV) lyLMP-1 open reading frame in tumor virus isolates: lack of correlation between Met129 status and EBV strain identity.
Erickson KD; Berger C; Coffin WF; Schiff E; Walling DM; Martin JM
J Virol; 2003 Apr; 77(7):4415-22. PubMed ID: 12634399
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic activity of Epstein-Barr virus latent membrane protein 1 (LMP-1) is down-regulated by lytic LMP-1.
Pandya J; Walling DM
J Virol; 2006 Aug; 80(16):8038-46. PubMed ID: 16873260
[TBL] [Abstract][Full Text] [Related]
4. Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion.
Erickson KD; Martin JM
Virology; 1997 Jul; 234(1):1-13. PubMed ID: 9234942
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus latent membrane protein-1 (LMP-1) and lytic LMP-1 localization in plasma membrane-derived extracellular vesicles and intracellular virions.
Vazirabadi G; Geiger TR; Coffin Iii WF; Martin JM
J Gen Virol; 2003 Aug; 84(Pt 8):1997-2008. PubMed ID: 12867629
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus latent membrane protein 1 (LMP-1) half-life in epithelial cells is down-regulated by lytic LMP-1.
Pandya J; Walling DM
J Virol; 2004 Aug; 78(15):8404-10. PubMed ID: 15254213
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.
Rowe M; Evans HS; Young LS; Hennessy K; Kieff E; Rickinson AB
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1575-86. PubMed ID: 2438376
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
Gradoville L; Kwa D; El-Guindy A; Miller G
J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane domains 1 and 2 of the latent membrane protein 1 of Epstein-Barr virus contain a lipid raft targeting signal and play a critical role in cytostasis.
Coffin WF; Geiger TR; Martin JM
J Virol; 2003 Mar; 77(6):3749-58. PubMed ID: 12610149
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-kappaB activity.
Bloss T; Kaykas A; Sugden B
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3227-3232. PubMed ID: 10567655
[TBL] [Abstract][Full Text] [Related]
11. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
Mori N; Morishita M; Tsukazaki T; Yamamoto N
Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
[TBL] [Abstract][Full Text] [Related]
12. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.
Takeshita H; Yoshizaki T; Miller WE; Sato H; Furukawa M; Pagano JS; Raab-Traub N
J Virol; 1999 Jul; 73(7):5548-55. PubMed ID: 10364303
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus latent membrane protein 1 induces CD69 expression through activation of nuclear factor-κB.
Ishikawa C; Mori N
Int J Oncol; 2013 May; 42(5):1786-92. PubMed ID: 23546309
[TBL] [Abstract][Full Text] [Related]
15. LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling.
Kaykas A; Worringer K; Sugden B
J Virol; 2002 Nov; 76(22):11551-60. PubMed ID: 12388716
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kappaB and different signaling pathways.
D'Addario M; Libermann TA; Xu J; Ahmad A; Menezes J
J Mol Biol; 2001 May; 308(3):501-14. PubMed ID: 11327783
[TBL] [Abstract][Full Text] [Related]
17. The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB.
Zuo L; Yu H; Liu L; Tang Y; Wu H; Yang J; Zhu M; Du S; Zhao L; Cao L; Li G; Lu J
Oncotarget; 2015 Dec; 6(38):41033-44. PubMed ID: 26517512
[TBL] [Abstract][Full Text] [Related]
18. Dual expression of Epstein-Barr virus, latent membrane protein-1 and human papillomavirus-16 E6 transform primary mouse embryonic fibroblasts through NF-κB signaling.
Shimabuku T; Tamanaha A; Kitamura B; Tanabe Y; Tawata N; Ikehara F; Arakaki K; Kinjo T
Int J Clin Exp Pathol; 2014; 7(5):1920-34. PubMed ID: 24966902
[TBL] [Abstract][Full Text] [Related]
19. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
[TBL] [Abstract][Full Text] [Related]
20. Sequence variations between two Epstein-Barr virus LMP 1 variants have no effect on the activation of NF-kappaB activity.
Yeh TS; Li SN; Wu CJ; Liu ST; Meng CL; Chang YS
DNA Cell Biol; 1997 Nov; 16(11):1311-9. PubMed ID: 9407003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
